Dr. Lawrence L. Wang, M.D., PHD
Dermatology (Dermatology Physician)
10004 Kennerly Rd, #375-b
St. Louis, MO 63128
Who else practices at this address →
St. Louis County includes dental (1% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Washington University School of Medicine (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,775
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: Washington University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
MO license 2005004447
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Dermatological Care, Inc. (11 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,775
- Services billed
- 11,430
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 5,357 | 771 |
| Established patient office or other outpatient visit, 20-29 minutes | 1,757 | 1,309 |
| Destruction of precancer skin growth, 1 growth | 1,189 | 878 |
| Biopsy of related skin growth, first growth | 710 | 608 |
| Biopsy of related skin growth, each additional growth | 312 | 198 |
| Destruction of skin growth, 1-14 growths | 291 | 252 |
| Established patient office or other outpatient visit, 30-39 minutes | 201 | 178 |
| New patient office or other outpatient visit, 30-44 minutes | 188 | 188 |
| Destruction of precancer skin growth, 15 or more growths | 137 | 98 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 86 | 76 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clobetasol Propionate Other prescribers in St. Louis, MO | 286 |
| Triamcinolone Acetonide Other prescribers in St. Louis, MO | 146 |
| Doxycycline Hyclate Other prescribers in St. Louis, MO | 131 |
| Betamethasone Diprop Augmented (betamethasone/propylene glyc) | 126 |
| Metronidazole Other prescribers in St. Louis, MO | 104 |
| Halobetasol Propionate | 48 |
| Clindamycin Phosphate Other prescribers in St. Louis, MO | 39 |
| Fluocinonide Other prescribers in St. Louis, MO | 37 |
| Desonide | 29 |
| Prednisone Other prescribers in St. Louis, MO | 27 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 203 payments worth $3,245 in total to this clinician.
| AbbVie Inc. | $448 |
|---|---|
| Novartis Pharmaceuticals Corporation | $326 |
| UCB, Inc. | $300 |
| Janssen Biotech, Inc. | $287 |
| Arcutis Biotherapeutics, Inc. | $259 |
| E.r. Squibb & Sons, L.l.c. | $233 |
| Botanix Sb Inc | $232 |
| Lilly USA, LLC | $213 |
| Food and Beverage | $3,041 |
|---|---|
| Education | $204 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. Dec 5, 2025 | Education in-kind | $89.99 |
| Janssen Biotech, Inc. Aug 18, 2025 | Education TREMFYA · Immunology · in-kind | $89.99 |
| Biofrontera Inc. Nov 3, 2025 | Education AMELUZ; BF-RHODOLED; RHODOLED XL · DERMATOLOGY · in-kind | $24.17 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.